Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplerenone in Prevention of Atrial Fibrillation Recurrences
NCT00647192Phase 2Terminated
- Sponsor
- Saarland University Medical Center
- Start
- Mar 2008
- Primary completion
- Feb 2012
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 2 trial of eplerenone in Atrial fibrillation (AFib), sponsored by Saarland University Medical Center. Started Mar 2008; status: terminated.
02
Drugs
eplerenone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00647192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00647192.